Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis - Wikidata - awgldk - TriplyDB

Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis

Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis

http://www.wikidata.org/entity/Q28253182

about

A cytomorphological and immunohistochemical profile of aggressive B-cell lymphoma: high clinical impact of a cumulative immunohistochemical outcome predictor score Tanzanian malignant lymphomas: WHO classification, presentation, ploidy, proliferation and HIV/EBV association.A unified 35-gene signature for both subtype classification and survival prediction in diffuse large B-cell lymphomas Influence of NK cell count on the survival of patients with diffuse large B-cell lymphoma treated with R-CHOP.Immunophenotype classification and therapeutic outcomes of Chinese primary gastrointestinal diffuse large B-cell lymphoma.Poor concordance among nine immunohistochemistry classifiers of cell-of-origin for diffuse large B-cell lymphoma: implications for therapeutic strategies Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era.Smooth muscle actin and s100p on non germinal centre diffuse large B cell lymphoma are adverse prognostic factors: pilot study.Significance of Bcl-2 and Bcl-6 immunostaining in B-Non Hodgkin's lymphoma.Maximum standardized uptake value on positron emission tomography/computed tomography predicts clinical outcome in patients with relapsed or refractory diffuse large B-cell lymphoma.A20 Mutation Is Not a Prognostic Marker for Activated B-Cell-Like Diffuse Large B-Cell Lymphoma.Immunophenotyping of chronic B-cell neoplasms: flow cytometry versus immunohistochemistry.Detection of the bcl-2 t(14;18) translocation and proto-oncogene expression in primary intraocular lymphoma.A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study.miR-21 expression predicts prognosis in diffuse large B-cell lymphoma MicroRNAs in diffuse large B-cell lymphoma.Prognostic Implication of Semi-quantitative Immunohistochemical Assessment of CD20 Expression in Diffuse Large B-Cell Lymphoma.Molecular genetic analysis of haematological malignancies II: Mature lymphoid neoplasms.Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3 Regulation of telomerase activity by interferon regulatory factors 4 and 8 in immune cells.Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: Report of the French-American-British (FAB) international study group.Prognostic Significance of in situ Phenotypic Marker Expression in Diffuse Large B-cell Lymphomas.Toward a systems biology approach to investigate cellular networks in normal and malignant B cells.Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials Expression IRF/MUM1>25% Predictor to Three-year Survival of Diffuse Large B Cell Lymphoma in the Immunochemotherapy Era.Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores.B-cell lymphomas involving Waldeyer's ring characterized by distinctive clinical and histopathological features: a comparison of pediatric to adult patients Current perspectives in genetics of "double-hit" lymphoma with possible clinical implications.Genetic and immunohistochemical characterization of Epstein-Barr virus-associated diffuse large B-cell lymphoma.SILAC-Based Quantitative Proteomic Analysis of Diffuse Large B-Cell Lymphoma Patients.Diffuse large B-cell lymphoma, not otherwise specified of the palate: A case report.Prognostic analysis of DLBCL patients and the role of upfront ASCT in high-intermediate and high-risk patients Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN.Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma.Bcl-2 and BLIMP-1 expression predict worse prognosis in gastric diffuse large B cell lymphoma (DLCBL) while other markers for nodal DLBCL are not useful.Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B-cell lymphoma patients with and without rheumatic disease.Bcl-6 protein expression, and not the germinal centre immunophenotype, predicts favourable prognosis in a series of primary nodal diffuse large B-cell lymphomas: a single centre experience.Canine lymphomas: association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival.Impact of germinal center and non-germinal center phenotypes on overall and failure-free survival after high-dose chemotherapy and auto-SCT in primary diffuse large B-cell lymphoma.Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP.

P2860

Q24653343-3E3A1AED-1E45-452B-94D2-EB5347FF63B3 Q33622062-E4606397-1F64-4583-982E-6626F8C1949F Q33698097-3C381C45-0DF3-4C1C-B7CF-11BCE714B639 Q34302472-0121D9A5-6790-44AF-B931-CF4872AC690E Q34314938-3747BE71-F49F-4F10-8AEF-2CBDB1E44DA6 Q34390837-70CE6355-68FE-4ACB-B9E1-D1431F3051B0 Q35193836-A4368D4B-6128-4E83-A598-1D8997D36B4C Q35689767-06B57D90-8A2C-4641-A96A-CC31B474014C Q35720027-7628F268-9FE3-4BCD-BA9B-2CEB552D3988 Q35800656-39E39435-FCEB-44CA-8A13-2A1BD6B1AC1C Q35881693-99BD84B4-C317-410E-B923-89429B7F5DFA Q35932225-7EE0645F-4DEB-4EF3-9F2C-AA745B6C7502 Q35933199-79500F26-7C2C-42FF-8B3A-5860710FB862 Q36171783-E497CF2A-1D46-4FA7-AEFD-CE56197CD8FC Q36464776-7FAE9D6F-55A7-4674-A70C-3107AEEE4D5A Q36524472-5AB6EB1A-DDCA-43A7-B21D-D068AE183CF2 Q36719078-B978AA84-59D3-4654-8DAC-65389C69CD9D Q36872779-F6FC7273-E1FF-4357-BCA6-5F49F25B708E Q36971217-36CA0862-876A-4185-988C-05EF72E5CA3D Q37072135-A5BC688E-EE2E-44B4-A601-AF8BC4C26E86 Q37265785-95753E19-9390-43C8-90EC-6AAD8B4B2BCA Q37280910-9C0E7F0D-411B-41C5-9BF3-ED3619E20C15 Q37385810-51AC5F08-B98B-4DD2-85E9-D3BC3D0737A8 Q37406798-985255BF-F1FB-4893-9498-789BBAEFC0D5 Q37470997-84680E5B-9792-46E7-9E15-9F0FF5D865E9 Q37635115-E0B4388E-2D4B-43EA-8400-E855B48F25A9 Q37706947-4B88FADA-3080-4727-839B-F75A77D63807 Q38162809-33E1FF6C-392A-4CA1-AD10-97ABF4D31FEA Q38395037-E8360219-3825-45B5-BEC9-E288A1D850BE Q40551018-CB400B8D-56EA-4DC2-813A-B84042D1642B Q41872455-02659B84-9ECC-41F9-B31C-DFB7AA2C0E46 Q42700683-77DDE264-397A-4E3F-A74E-7E3C78370BF7 Q42807725-E04BFCC1-9E6C-4424-8EBF-87246CFFBF2C Q42923456-A5BAB79E-DC2E-41BC-B462-2143144E9B87 Q43816514-5EE72EBD-D815-41A6-99FD-A6AC66BA71CA Q44455716-495EE885-3067-4AF5-BD92-03B0E0E8BA42 Q45128237-D7519A07-1491-4F4B-8BB8-DE4DF27E61E4 Q45358793-90322FB5-4C1D-4BE0-A04B-0963BE61A759 Q45382904-FCEE05D6-70CA-4DD3-9F97-EAB0E3F69F86 Q46008262-15DACBF9-562F-45F6-9A6F-FFC9803F8913

P2860

Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis

http://www.wikidata.org/entity/Q28253182

description

2005 nî lūn-bûn

@nan

2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Evaluation of immunophenotype ...... ma and its impact on prognosis

@ast

Evaluation of immunophenotype ...... ma and its impact on prognosis

@en

Evaluation of immunophenotype ...... ma and its impact on prognosis

@nl

type

label

Evaluation of immunophenotype ...... ma and its impact on prognosis

@ast

Evaluation of immunophenotype ...... ma and its impact on prognosis

@en

Evaluation of immunophenotype ...... ma and its impact on prognosis

@nl

prefLabel

Evaluation of immunophenotype ...... ma and its impact on prognosis

@ast

Evaluation of immunophenotype ...... ma and its impact on prognosis

@en

Evaluation of immunophenotype ...... ma and its impact on prognosis

@nl

P1433

Q28253182-929BBD7E-2FA1-4A2B-8B31-CC983DFDFB6B

P1476

Q28253182-BACE0AA9-3B95-4A1F-8CFE-7A9785144140

P2093

Q28253182-1962B0C5-A58C-46E7-B1F5-B768554C994D

Q28253182-2CCBEF1B-3DBD-4399-AD49-9595ED0DB7A2

Q28253182-31523EA0-AEC8-4735-BD85-BDE9761524CF

Q28253182-38943037-340E-4D20-94B0-F5E29D0D907E

Q28253182-3F02499D-4518-4704-BA88-2E549233DAB0

Q28253182-3F6CB85B-4B2C-4BCB-B13F-C268990DCCB8

Q28253182-5948D673-9ED9-45A0-B5BE-CE4EEE26DADE

Q28253182-5EE72149-B3CE-401E-8DB0-0FD0C6ABEDF4

Q28253182-6C242E4D-F107-46CF-9BD9-573E5C1818B0

Q28253182-756DF732-B415-48C3-8E6E-3065DC3E81E7

P2860

Q28253182-032C0C63-465F-4A2D-BF34-6F2D91F697CA

Q28253182-0387E415-1B58-4F90-AFEF-A6A3947638A2

Q28253182-16F131B6-0B3B-4FD2-96A7-769EDBB8A336

Q28253182-3057FFCE-2665-4C75-AD0D-EB5F50579845

Q28253182-41C82E25-5936-456C-BB22-242DF4FD6770

Q28253182-479BED12-42E4-4198-ADD0-07B50067AB74

Q28253182-572B46A9-8845-446A-8717-CD9C5DC23BE0

Q28253182-5D61C837-D55B-446B-9C55-F8AEBBF3CD5C

Q28253182-69573B09-CFB6-42B9-A3C5-83F15CD54449

Q28253182-6FF79F9C-0A06-4462-A51D-E86CDDAA5A88

P2888

Q28253182-F92945FB-2556-4FD8-84D1-7F72A559F5DD

P304

Q28253182-618D1B02-AEBD-4BE2-B337-03592372A4EF

P31

Q28253182-CE0A4FBD-436F-431E-825C-B8BFC6137D3F

P356

Q28253182-490BC253-2182-459F-B1A3-FF4D480429F1

P407

Q28253182-28450620-1050-4B0B-928A-8C88CA85D532

P433

Q28253182-DD0D5780-C96C-4D2B-9095-C084326A91BA

P478

Q28253182-AE8479F8-188E-40B7-9E15-4EEC03A6FB1E

P50

Q28253182-9B211F0A-3C2E-4B9E-8D5B-E3A770E1D819

Q28253182-F7D76F76-359C-4629-8D49-A854C84E76C1

P577

Q28253182-11A007FD-067D-4220-B667-E31E964F6993

P5875

Q28253182-4101E26E-2465-48F6-8742-F8D42A6B74B3

P6179

Q28253182-C541AB18-4717-4AC8-80DD-169B301ACC8D

P698

Q28253182-8A4083AC-6455-4226-94B9-84588DBA0EEF

P356

MODPATHOL.3800396

P1433

Modern Pathology

P1476

Evaluation of immunophenotype ...... ma and its impact on prognosis

@en

P2093

Carin Backlin

http://www.w3.org/2001/XMLSchema#string

Christer Sundström

http://www.w3.org/2001/XMLSchema#string

Eva Cavallin-Ståhl

http://www.w3.org/2001/XMLSchema#string

Gunilla Enblad

http://www.w3.org/2001/XMLSchema#string

Hans Hagberg

http://www.w3.org/2001/XMLSchema#string

Johan Linderoth

http://www.w3.org/2001/XMLSchema#string

Majlis Book

http://www.w3.org/2001/XMLSchema#string

Martin Erlanson

http://www.w3.org/2001/XMLSchema#string

Mats Jerkeman

http://www.w3.org/2001/XMLSchema#string

Mattias Berglund

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of lymphocyte apoptosis by interferon regulatory factor 4 (IRF-4)

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

Detection of germinal center B-cell lymphoma in archival specimens: critical evaluation of Bcl-6 protein expression in diffuse large B-cell lymphoma of the tonsil.

BCL2 overexpression in diffuse large B-cell lymphoma.

Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes.

Diffuse large cell lymphoma.

P2888

modpathol.3800396

P304

1113-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.3800396

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Eva Cavallin-Ståhl

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7820430

http://www.w3.org/2001/XMLSchema#string

P6179

1053221537

http://www.w3.org/2001/XMLSchema#string

P698

15920553

http://www.w3.org/2001/XMLSchema#string